Literature DB >> 23686798

McCarus Cosmetic Hysterectomy™ - a patient-centric approach.

Steven D McCarus1.   

Abstract

As patients are diagnosed with a health condition that requires a hysterectomy, surgical recommendations are generally discussed. Surgical options for a variety of procedures have expanded greatly in the past decade because of the development of innovations including, but not limited to, robots, advanced bipolar energy systems, HD cameras, single-site access systems, minilaparoscopic instruments, and novel uterine manipulators. These advances allow the surgeon to consider an expanded variety of procedures that may not only improve patient outcomes but also accommodate patient preferences. However, inherent bias directly related to the surgeon's specific view may influence decisions limiting hysterectomy options offered to patients. As general gynecological surgeons, we are not only empowered but also obligated to provide patients with expanded hysterectomy options that fit the indications and clinical needs of our patients. - Cosmetic minimally invasive surgery improved cosmesis compared with standard trocars. - Cosmetic minimally invasive surgery needs no skin or fascial closure. - McCarus Cosmetic Hysterectomy™ affords benefits of minimally invasive surgery. - Cosmetic minimally invasive surgery represents the next evolution in minimally invasive surgery. - Cosmetic minimally invasive surgery allows expansion of hysterectomy options for benign disease.

Entities:  

Mesh:

Year:  2013        PMID: 23686798

Source DB:  PubMed          Journal:  Surg Technol Int        ISSN: 1090-3941


  2 in total

1.  A SAGES technology and value assessment and pediatric committee evaluation of mini-laparoscopic instrumentation.

Authors:  Thom E Lobe; Lucian Panait; Giovanni Dapri; Peter M Denk; David Pechman; Luca Milone; Stefan Scholz; Bethany J Slater
Journal:  Surg Endosc       Date:  2022-08-19       Impact factor: 3.453

2.  Senhance Robotic Platform System for Gynecological Surgery.

Authors:  Steven D McCarus
Journal:  JSLS       Date:  2021 Jan-Mar       Impact factor: 2.172

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.